Clinuvel Pharmaceuticals
CUV.AX
#7502
Rank
C$0.57 B
Marketcap
C$11.48
Share price
1.78%
Change (1 day)
11.97%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2025: C$46.33 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are C$62.5 Million. In 2025 the company made an earning of C$46.33 Million, an increase over its 2024 earnings that were of C$46.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025C$46.33 M0.26%
2024C$46.21 M11.35%
2023C$41.5 M28.31%
2022C$32.34 M22.8%
2021C$26.34 M112.63%
2020C$12.38 M-28.73%
2019C$17.38 M32.79%
2018C$13.09 M75.41%
2017C$7.46 M-332.52%
2016-C$3.21 Million-70.68%
2015-C$10.95 Million53.78%
2014-C$7.12 Million-16.1%
2013-C$8.49 Million-37.92%
2012-C$13.67 Million-18.19%
2011-C$16.71 Million25.31%
2010-C$13.34 Million-21.53%
2009-C$17 Million-11.27%
2008-C$19.16 Million80.4%
2007-C$10.62 Million-2.46%
2006-C$10.89 Million-5.35%
2005-C$11.5 Million60.55%
2004-C$7.17 Million97.37%
2003-C$3.63 Million50.62%
2002-C$2.41 Million121.22%
2001-C$1.09 Million254.48%
2000-C$0.31 Million